Home › Department of Health and Human Services › Contract 75A50122C00031
CROSSJECT SA
Federal contract 75A50122C00031 with Department of Health and Human Services, currently held by CROSSJECT SA.
Expires 2027-06-21 · in 10 months
- Incumbent
- CROSSJECT SA
- Awarding agency
- Department of Health and Human Services
- Sub-agency
- Office of Assistant Secretary for Preparedness and Response
- Industry (NAICS)
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Ceiling value
- $104,152,986
- Period of performance
- 2022-06-22 to 2027-06-21
- Award ID
- 75A50122C00031
Contract description
ADVANCED RESEARCH AND DEVELOPMENT AND DELIVERY OF ADULT AND PEDIATRIC MIDAZOLAM AUTOINJECTORS THAT HAVE RECEIVED EMERGENCY USE AUTHORIZATION (EUA) OR FDA APPROVAL FOR THE TREATMENT OF STATUS EPILEPTICUS SEIZURES IN ADULT AND PEDIATRIC POPULATIONS (2+
Recompete context. This contract's current period of performance ends on
2027-06-21 (in 10 months). When a period of performance ends, the
agency typically either recompetes the work, extends the incumbent, or exercises a remaining option.
An end date is the earliest reliable public signal that a follow-on may be coming, which is why capture
teams track it. It is not a guarantee of a recompete. All figures are drawn from
USAspending.gov (U.S. Treasury) and are public domain.
Other Department of Health and Human Services contracts on the cliff
| Incumbent | Ceiling value | Ends | Expiry |
|---|---|---|---|
| NOVITAS SOLUTIONS, INC. | $921,080,482 | 2026-08-31 | expiring now |
| VERIZON BUSINESS NETWORK SERVICES LLC | $406,353,536 | 2026-08-31 | expiring now |
| LEIDOS BIOMEDICAL RESEARCH INC | $371,787,375 | 2026-08-30 | expiring now |
| LEIDOS, INC. | $152,046,866 | 2026-08-31 | expiring now |
| LEIDOS BIOMEDICAL RESEARCH INC | $87,806,507 | 2026-08-30 | expiring now |
| LEIDOS BIOMEDICAL RESEARCH INC | $80,917,684 | 2026-08-31 | expiring now |